{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "31915300",
  "DateCompleted": {
    "Year": "2021",
    "Month": "01",
    "Day": "29"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "06",
    "Day": "10"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "eaay4860",
      "10.1126/scitranslmed.aay4860"
    ],
    "Journal": {
      "ISSN": "1946-6242",
      "JournalIssue": {
        "Volume": "12",
        "Issue": "525",
        "PubDate": {
          "Year": "2020",
          "Month": "Jan",
          "Day": "08"
        }
      },
      "Title": "Science translational medicine",
      "ISOAbbreviation": "Sci Transl Med"
    },
    "ArticleTitle": "Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-\u03b2.",
    "Abstract": {
      "AbstractText": [
        "Cancer-associated thrombocytosis and high concentrations of circulating transforming growth factor-\u03b21 (TGF-\u03b21) are frequently observed in patients with progressive cancers. Using genetic and pharmacological approaches, we show a direct link between thrombin catalytic activity and release of mature TGF-\u03b21 from platelets. We found that thrombin cleaves glycoprotein A repetitions predominant (GARP), a cell surface docking receptor for latent TGF-\u03b21 (LTGF-\u03b21) on platelets, resulting in liberation of active TGF-\u03b21 from the GARP-LTGF-\u03b21 complex. Furthermore, systemic inhibition of thrombin obliterates TGF-\u03b21 maturation in platelet releasate and rewires the tumor microenvironment toward favorable antitumor immunity, which translates into efficient cancer control either alone or in combination with programmed cell death 1-based immune checkpoint blockade therapy. Last, we demonstrate that soluble GARP and GARP-LTGF-\u03b21 complex are present in the circulation of patients with cancer. Together, our data reveal a mechanism of cancer immune evasion that involves thrombin-mediated GARP cleavage and the subsequent TGF-\u03b21 release from platelets. We propose that blockade of GARP cleavage is a valuable therapeutic strategy to overcome cancer's resistance to immunotherapy."
      ],
      "CopyrightInformation": "Copyright \u00a9 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works."
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-3849-9869"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology and Immunology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA."
          }
        ],
        "LastName": "Metelli",
        "ForeName": "Alessandra",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Pelotonia Institute for Immuno-Oncology, The James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA."
          }
        ],
        "LastName": "Wu",
        "ForeName": "Bill X",
        "Initials": "BX"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Pelotonia Institute for Immuno-Oncology, The James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA."
          }
        ],
        "LastName": "Riesenberg",
        "ForeName": "Brian",
        "Initials": "B"
      },
      {
        "Identifier": [
          "0000-0001-9998-5716"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology and Immunology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA."
          }
        ],
        "LastName": "Guglietta",
        "ForeName": "Silvia",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Hauptman Woodward Medical Research Institute, Buffalo, NY 14203, USA."
          }
        ],
        "LastName": "Huck",
        "ForeName": "John D",
        "Initials": "JD"
      },
      {
        "Identifier": [
          "0000-0002-1423-6327"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology and Immunology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA."
          }
        ],
        "LastName": "Mills",
        "ForeName": "Catherine",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Pelotonia Institute for Immuno-Oncology, The James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA."
          }
        ],
        "LastName": "Li",
        "ForeName": "Anqi",
        "Initials": "A"
      },
      {
        "Identifier": [
          "0000-0001-6029-2664"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology and Immunology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA."
          }
        ],
        "LastName": "Rachidi",
        "ForeName": "Saleh",
        "Initials": "S"
      },
      {
        "Identifier": [
          "0000-0002-5145-7591"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology and Immunology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA."
          }
        ],
        "LastName": "Krieg",
        "ForeName": "Carsten",
        "Initials": "C"
      },
      {
        "Identifier": [
          "0000-0003-4748-0286"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology and Immunology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Surgery, Medical University of South Carolina, Charleston, SC 29425, USA."
          }
        ],
        "LastName": "Rubinstein",
        "ForeName": "Mark P",
        "Initials": "MP"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Hauptman Woodward Medical Research Institute, Buffalo, NY 14203, USA."
          }
        ],
        "LastName": "Gewirth",
        "ForeName": "Daniel T",
        "Initials": "DT"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC 29425, USA."
          }
        ],
        "LastName": "Sun",
        "ForeName": "Shaoli",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA."
          }
        ],
        "LastName": "Lilly",
        "ForeName": "Michael B",
        "Initials": "MB"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC 29425, USA."
          }
        ],
        "LastName": "Wahlquist",
        "ForeName": "Amy H",
        "Initials": "AH"
      },
      {
        "Identifier": [
          "0000-0003-3002-1921"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Pelotonia Institute for Immuno-Oncology, The James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Division of Medical Oncology, The Ohio State University, Columbus, OH 43210, USA."
          }
        ],
        "LastName": "Carbone",
        "ForeName": "David P",
        "Initials": "DP"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Pelotonia Institute for Immuno-Oncology, The James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH 43210, USA."
          }
        ],
        "LastName": "Yang",
        "ForeName": "Yiping",
        "Initials": "Y"
      },
      {
        "Identifier": [
          "0000-0002-5198-0796"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology and Immunology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA."
          }
        ],
        "LastName": "Liu",
        "ForeName": "Bei",
        "Initials": "B"
      },
      {
        "Identifier": [
          "0000-0003-4603-927X"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology and Immunology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA. zihai.li@osumc.edu."
          },
          {
            "Identifier": [],
            "Affiliation": "Pelotonia Institute for Immuno-Oncology, The James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Division of Medical Oncology, The Ohio State University, Columbus, OH 43210, USA."
          }
        ],
        "LastName": "Li",
        "ForeName": "Zihai",
        "Initials": "Z"
      }
    ],
    "GrantList": [
      {
        "GrantID": "R01 DK105033",
        "Acronym": "DK",
        "Agency": "NIDDK NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 CA188419",
        "Acronym": "CA",
        "Agency": "NCI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 CA213290",
        "Acronym": "CA",
        "Agency": "NCI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "P01 CA186866",
        "Acronym": "CA",
        "Agency": "NCI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 CA193167",
        "Acronym": "CA",
        "Agency": "NCI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 AI077283",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Sci Transl Med",
    "NlmUniqueID": "101505086",
    "ISSNLinking": "1946-6234"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Immune Checkpoint Inhibitors"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "LRRC32 protein, human"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Latent TGF-beta Binding Proteins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Lrrc32 protein, mouse"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Membrane Proteins"
    },
    {
      "RegistryNumber": "EC 3.4.21.5",
      "NameOfSubstance": "Thrombin"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Blood Platelets"
    },
    {
      "QualifierName": [
        "drug effects",
        "immunology",
        "pathology"
      ],
      "DescriptorName": "Carcinogenesis"
    },
    {
      "QualifierName": [
        "drug effects",
        "metabolism"
      ],
      "DescriptorName": "Cell Membrane"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Disease Progression"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Immune Checkpoint Inhibitors"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Immune Evasion"
    },
    {
      "QualifierName": [
        "blood",
        "metabolism"
      ],
      "DescriptorName": "Latent TGF-beta Binding Proteins"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Membrane Proteins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mice, Inbred BALB C"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mice, Inbred C57BL"
    },
    {
      "QualifierName": [
        "immunology",
        "pathology"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Protein Binding"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Proteolysis"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Thrombin"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Tumor Microenvironment"
    }
  ],
  "CoiStatement": "<b>Competing interests:</b> Consulting: Alphamab and Henlius Biotech (Z.L.). Sponsored research agreement: Bristol-Myers Squibb (Z.L. and B.X.W.). Part of the work described in the study was included in a pending patent application (PCT/US2017/025037, Methods for treatment and diagnosis of cancer by targeting GARP and for providing effective immunotherapy alone or in combination, Z.L.). All other authors declare that they have no competing interests."
}